Avidity Biosciences, Inc (RNAM) — Financial Flexibility Index
Avidity Biosciences, Inc (RNAM) has a Financial Flexibility Index of -0.61x as of December 2025. Free cash flow of $-164.26 Million (operating CF $-169.77 Million minus capex $5.51 Million) represents -1% of total liabilities ($269.45 Million). Check RNAM cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Avidity Biosciences, Inc Financial Flexibility Index (2018–2025)
Historical Financial Flexibility Index trend for Avidity Biosciences, Inc across 8 annual periods. For the full cash flow conversion analysis, see RNAM cash generation efficiency.
Annual Financial Flexibility Index for Avidity Biosciences, Inc (2018–2025)
Year-by-year free cash flow to debt coverage for Avidity Biosciences, Inc. Explore Avidity Biosciences, Inc cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -2.36x | $-637.12 Million | $-650.44 Million | $269.45 Million | ▼ -11.8% |
| 2024 | -2.11x | $-293.80 Million | $-300.87 Million | $138.94 Million | ▼ -135.3% |
| 2023 | -0.90x | $-114.84 Million | $-119.06 Million | $127.79 Million | ▲ +59.1% |
| 2022 | -2.20x | $-133.44 Million | $-136.27 Million | $60.73 Million | ▼ -11.4% |
| 2021 | -1.97x | $-91.07 Million | $-94.81 Million | $46.15 Million | ▼ -51.6% |
| 2020 | -1.30x | $-36.02 Million | $-37.12 Million | $27.68 Million | ▼ -7851.3% |
| 2019 | 0.02x | $2.73 Million | $2.49 Million | $162.26 Million | ▲ +107.9% |
| 2018 | -0.21x | $-9.61 Million | $-9.65 Million | $45.11 Million | — |